Melatonin Pharma Nord (Melatonin)

Melatonin binds to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, mimicking the natural hormone released at night. This interaction signals the body that it is time to sleep, reducing wake‑promoting signals and facilitating the transition to sleep.

The appropriate dose of Melatonin Pharma Nord is determined by a prescriber based on the individual’s age, condition, and response to therapy. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety data for melatonin in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk, and after consultation with a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melatonin differs from traditional hypnotics such as benzodiazepines or Z‑drugs because it works by resetting the circadian clock rather than directly depressing the central nervous system. This mechanism often results in fewer next‑day residual effects, but efficacy may vary depending on the underlying sleep disorder.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Melatonin Pharma Nord is taken orally. The tablet or capsule should be swallowed whole with water, typically 30–60 minutes before the desired bedtime, unless the prescribing clinician advises a different timing.

Serious risks, though rare, include severe allergic reactions such as rash, itching, or swelling, as well as mood changes like depression or irritability. Patients experiencing any of these symptoms should seek medical attention promptly.

Melatonin should be avoided in individuals with known hypersensitivity to melatonin or any excipients in the formulation, and it is not recommended for children, adolescents, or pregnant women unless specifically prescribed by a healthcare professional.